Medifast Inc
MED
Market Cap$147.39M
Close$
$41.67
210.7% upside
Current Fair Value
210.7% upsideUndervalued by 210.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $147.39 Million |
|---|---|
| Enterprise Value | $64.45 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $0.19 |
| Beta | 0.98 |
| Outstanding Shares | 10,948,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -20.98 |
|---|---|
| PEG | 19.2 |
| Price to Sales | 0.27 |
| Price to Book Ratio | 0.71 |
| Enterprise Value to Revenue | 0.12 |
| Enterprise Value to EBIT | -10.33 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Medifast Inc
550 employees
CEO: Daniel Chard Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and ...